Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Alendronate in Postmenopausal Women
NCT00460057Phase 4Completed
- Sponsor
- Eulji University Hospital
- Start
- Mar 2006
- Primary completion
- Dec 2006
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in osteoporosis comparing Alendronate with Placebo (2 arms). Primary endpoint: Changes of bone turnover markers at 12 weeks. Started Mar 2006; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00460057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460057.